NKTX
3.43 USD
0.02 (0.56%)
Last updated Oct 30, 1:30 PM
Yesterday High
$3.49
Yesterday Low
$3.25
52w High
$15.71
52w Low
$1.91
Market Cap.
$241.7M
52w Change
79.32%
This is a preview of the full version of Prosperse
Trending News
Nkarta to Participate in Upcoming Investor Conference
Nkarta, Inc., a biopharmaceutical company developing engineered natural killer (NK) cell therapies, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
N/A
Sep 3, 2024
Why Nkarta Stock Is Soaring Today
Nkarta's stock surged 11.1% after Raymond James upgraded the stock to a strong buy, citing the company's strong cash position and the potential of its lead candidate NKX019 in treating autoimmune diseases.
Keith Speights
Aug 14, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
US Stocks End Week Positively with Boost from Tech Sector and Solid Consumer Sentiment
Date: Oct 25, 2024
TSMC Achieves Higher Production Yields in Arizona Facility Compared to Taiwan
Date: Oct 25, 2024
Federal Judge Blocks Tapestry's $8.5 Billion Acquisition of Capri Holdings Due to Antitrust Concerns
Date: Oct 25, 2024
2024 Presidential Race Deadlock: Trump and Harris Tied in Pivotal Swing States
Date: Oct 24, 2024
Stocks Rebound as Tesla Leads Surge; UPS Gains Highlight Economic Trends
Date: Oct 24, 2024